ADARx Pharmaceuticals · OpenAPI Overlay 1.0.0

API Evangelist enhancements for the ADARx Pharmaceuticals Content API

6 actions 6 updates update extends openapi/adarx-pharmaceuticals-content-openapi.yml

Generated by API Evangelist Written by API Evangelist tooling for ADARx Pharmaceuticals's API. It is a proposal applied on top of the contract, not a document ADARx Pharmaceuticals publishes.

View Overlay File View on GitHub Overlay Specification

What the actions change

x-apievangelist-profilex-apievangelist-derivedx-apievangelist-provider-published-specx-apievangelist-surface-classx-apievangelist-verifiedx-artifactsx-poll-strategyx-content-populated

Targets 5

$.info

$.paths['/wp/v2/posts'].get

$.paths['/wp/v2/users'].get

$.paths['/yoast/v1/get_head'].get

$.components.schemas.Post

OpenAPI Overlay

overlay: 1.0.0
info:
  title: API Evangelist enhancements for the ADARx Pharmaceuticals Content API
  version: 1.0.0
extends: openapi/adarx-pharmaceuticals-content-openapi.yml
x-generated: '2026-08-06'
x-method: generated
x-note: >-
  ADARx Pharmaceuticals publishes no OpenAPI. The document this overlay extends is itself an API
  Evangelist derivation of the WordPress route index at https://www.adarx.com/wp-json/. This
  overlay records the API Evangelist assessment layered on top of it, so the derivation stays a
  faithful description of the observed surface and the opinion stays separable from it.
actions:
- target: $.info
  update:
    x-apievangelist-profile: https://apis.io/providers/adarx-pharmaceuticals/
    x-apievangelist-derived: true
    x-apievangelist-provider-published-spec: false
    x-apievangelist-surface-class: incidental-cms-api
    x-apievangelist-verified: '2026-08-06'
- target: $.info
  update:
    x-artifacts:
      authentication: authentication/adarx-pharmaceuticals-authentication.yml
      conventions: conventions/adarx-pharmaceuticals-conventions.yml
      errors: errors/adarx-pharmaceuticals-problem-types.yml
      conformance: conformance/adarx-pharmaceuticals-conformance.yml
      lifecycle: lifecycle/adarx-pharmaceuticals-lifecycle.yml
      data_model: data-model/adarx-pharmaceuticals-data-model.yml
      json_ld: json-ld/adarx-pharmaceuticals-json-ld.yml
      well_known: well-known/adarx-pharmaceuticals-well-known.yml
      domain_security: security/adarx-pharmaceuticals-domain-security.yml
      skills: skills/_index.yml
- target: $.paths['/wp/v2/posts'].get
  update:
    x-poll-strategy: >-
      No ETag, Last-Modified or Cache-Control is returned. Use modified_after against the highest
      `modified` seen. No rate-limit header of any kind is advertised; poll no more than hourly.
    x-content-populated: true
- target: $.paths['/wp/v2/users'].get
  update:
    x-exposure-note: >-
      This endpoint returns 200 anonymously on this install, which is not the WordPress default
      posture for a corporate site. It exposes two author display names and slugs (no email
      addresses). Recorded as an observation, not a vulnerability.
- target: $.paths['/yoast/v1/get_head'].get
  update:
    x-structured-data-gap: >-
      The returned schema.org @graph carries WebPage, ImageObject, BreadcrumbList and WebSite nodes
      but no Organization node, so ADARx company identity is not machine readable.
- target: $.components.schemas.Post
  update:
    x-missing-domain-model: >-
      The ADARx clinical pipeline — ADX-038 (agazisiran), ADX-324 (onvuzosiran), ADX-626, ADX-077,
      ADX-199 with their targets, indications and phases — has no representation in this schema or
      any other. It exists only as rendered HTML inside page id 10. This is the largest gap between
      what ADARx knows and what ADARx publishes machine-readably.